NCT01091584

Brief Summary

The use of interventions for cancer-related distress is important to reduce this distress. Distress has a negative impact on quality of life, the recovery during and after treatment and may even adversely affect survival. There is insufficient attention to the systematic approach to psychosocial problems in cancer patients in the Netherlands. A task force discussed and studied which instrument measures psychosocial problems best. The distress thermometer ("lastmeter") had the best results. A guideline is written to use the distress thermometer for patients with cancer and will be used in hospitals in the Netherlands. However, it is not clear what the effects are of the use of the distress thermometer on the psychosocial wellbeing of the patient. Furthermore, it is also unknown whether the use of the distress thermometer leads to cost-effective care. The study focuses on the use of the distress thermometer in breast cancer patients. An efficiency study (RCT) will be conducted to evaluate the systematic use of the distress thermometer and its discussion by a nurse as compared to the usual care provided to outpatients who are treated with curative intent for breast cancer by their treating physicians. The clinical and economic impact of the use of the Distress thermometer will be assessed in comparison with usual care.The recruitment of patients will take place in the out-patient clinic of a university hospital. Patients will be followed from diagnose until two years after finishing their treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
193

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2010

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

March 17, 2010

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 24, 2010

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2013

Completed
3.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2016

Completed
Last Updated

December 5, 2016

Status Verified

November 1, 2016

Enrollment Period

2.9 years

First QC Date

March 17, 2010

Last Update Submit

December 2, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Subscale quality of life of the questionnaire: EORTC QLQ C30

    Subscale quality of life of the questionnaire: EORTC QLQ C30

    After each treatment completion, during follow up; first year every 3 months, second year every 6 months

Secondary Outcomes (1)

  • Other subscales

    After each treatment completion, during follow up; first year every 3 months, second year every 6 months

Study Arms (2)

intervention group

ACTIVE COMPARATOR

The intervention is to apply the distress thermometer as written in the guideline written by 'Vereniging Integrale Kankercentra' title: 'Detecteren behoefte psychosociale zorg. The distress thermometer is collected from the experimental group and then discussed by a trained nurse.

Device: distress thermometer

control group

NO INTERVENTION

usual care

Interventions

to apply the distress thermometer as written in the guideline written by 'Vereniging Integrale Kankercentra' title: 'Detecteren behoefte psychosociale zorg. The distress thermometer is collected from the experimental group and then discussed by a trained nurse

intervention group

Eligibility Criteria

Age18 Years - 100 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Histologically proven malignancy of the breast
  • Curative treatment
  • Dominated the dutch language
  • Age \> 18 year

You may not qualify if:

  • Previously treated for a malignancy
  • Psychiatric problems that adherence this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Medical Centre Nijmegen

Nijmegen, 6500, Netherlands

Location

Related Publications (1)

  • Ploos van Amstel FK, Prins JB, van der Graaf WT, Peters ME, Ottevanger PB. The effectiveness of a nurse-led intervention with the distress thermometer for patients treated with curative intent for breast cancer: design of a randomized controlled trial. BMC Cancer. 2016 Jul 25;16:520. doi: 10.1186/s12885-016-2565-x.

Study Officials

  • P. B. Ottevanger, Dr

    University Medical Centre Nijmegen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 17, 2010

First Posted

March 24, 2010

Study Start

March 1, 2010

Primary Completion

February 1, 2013

Study Completion

July 1, 2016

Last Updated

December 5, 2016

Record last verified: 2016-11

Locations